nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—S100A13—heart—dilated cardiomyopathy	0.0309	0.127	CbGeAlD
Amlexanox—S100A12—heart—dilated cardiomyopathy	0.0305	0.126	CbGeAlD
Amlexanox—FGF1—cardiac ventricle—dilated cardiomyopathy	0.029	0.119	CbGeAlD
Amlexanox—FGF1—myocardium—dilated cardiomyopathy	0.0273	0.112	CbGeAlD
Amlexanox—PDE4D—heart—dilated cardiomyopathy	0.0203	0.0838	CbGeAlD
Amlexanox—FGF1—heart—dilated cardiomyopathy	0.019	0.0783	CbGeAlD
Amlexanox—PDE4A—heart—dilated cardiomyopathy	0.018	0.0741	CbGeAlD
Amlexanox—PDE4B—cardiac ventricle—dilated cardiomyopathy	0.0163	0.0673	CbGeAlD
Amlexanox—FGF1—cardiac atrium—dilated cardiomyopathy	0.0163	0.067	CbGeAlD
Amlexanox—PDE4B—myocardium—dilated cardiomyopathy	0.0154	0.0633	CbGeAlD
Amlexanox—PDE4B—heart—dilated cardiomyopathy	0.0107	0.0442	CbGeAlD
Amlexanox—PDE4B—cardiac atrium—dilated cardiomyopathy	0.00918	0.0378	CbGeAlD
Amlexanox—IL3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00218	0.00288	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00218	0.00288	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	0.00208	0.00275	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—RAC1—dilated cardiomyopathy	0.00208	0.00274	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—RAC1—dilated cardiomyopathy	0.00208	0.00274	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—CD36—dilated cardiomyopathy	0.00208	0.00274	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00207	0.00273	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00203	0.00268	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00199	0.00263	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00198	0.00262	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00198	0.00262	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00197	0.0026	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—RAC1—dilated cardiomyopathy	0.00196	0.00258	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00195	0.00258	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.00194	0.00256	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—RAF1—dilated cardiomyopathy	0.00193	0.00255	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.00185	0.00244	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00184	0.00243	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00179	0.00236	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—EGFR—dilated cardiomyopathy	0.00168	0.00222	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00168	0.00222	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.00165	0.00218	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00159	0.0021	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00158	0.00209	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—RAF1—dilated cardiomyopathy	0.00158	0.00209	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	0.00156	0.00205	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00152	0.00201	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—EGFR—dilated cardiomyopathy	0.00152	0.002	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CD36—dilated cardiomyopathy	0.0015	0.00198	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—RAF1—dilated cardiomyopathy	0.00149	0.00196	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—EGFR—dilated cardiomyopathy	0.00148	0.00195	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—RAF1—dilated cardiomyopathy	0.00148	0.00195	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.00147	0.00194	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—EGFR—dilated cardiomyopathy	0.00147	0.00194	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—RAF1—dilated cardiomyopathy	0.00146	0.00193	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00145	0.00191	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—dilated cardiomyopathy	0.00143	0.00189	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—RAC1—dilated cardiomyopathy	0.00141	0.00187	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—RAC1—dilated cardiomyopathy	0.00141	0.00186	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0014	0.00185	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0014	0.00185	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	0.00138	0.00182	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	0.00138	0.00182	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—RAF1—dilated cardiomyopathy	0.00138	0.00182	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—RAF1—dilated cardiomyopathy	0.00136	0.0018	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.00135	0.00179	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.00135	0.00178	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00132	0.00174	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.0013	0.00172	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—RAF1—dilated cardiomyopathy	0.0013	0.00171	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.0013	0.00171	CbGpPWpGaD
Amlexanox—IL3—Immune System—ITGB1—dilated cardiomyopathy	0.00128	0.00169	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00127	0.00168	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00127	0.00168	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00126	0.00166	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00124	0.00163	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.00122	0.00161	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00122	0.00161	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00122	0.00161	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00118	0.00156	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00118	0.00156	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00117	0.00155	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00117	0.00155	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00116	0.00153	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00116	0.00153	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00114	0.00151	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.00113	0.0015	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00113	0.0015	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00112	0.00148	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00111	0.00146	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00111	0.00146	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.0011	0.00145	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00109	0.00144	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD36—dilated cardiomyopathy	0.00109	0.00144	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	0.00108	0.00143	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00108	0.00143	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00108	0.00142	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00108	0.00142	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00107	0.00142	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00107	0.00142	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00107	0.00142	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	0.00107	0.00141	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00105	0.00139	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00105	0.00139	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00105	0.00139	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00104	0.00138	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00103	0.00136	CbGpPWpGaD
Amlexanox—IL3—Immune System—RAC1—dilated cardiomyopathy	0.00103	0.00135	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ITGB1—dilated cardiomyopathy	0.00102	0.00135	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00102	0.00135	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—EGFR—dilated cardiomyopathy	0.00102	0.00135	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—EGFR—dilated cardiomyopathy	0.00101	0.00134	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.00101	0.00133	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—EGFR—dilated cardiomyopathy	0.001	0.00133	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000997	0.00132	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000996	0.00131	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000989	0.00131	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000979	0.00129	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000977	0.00129	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000974	0.00129	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000974	0.00129	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000966	0.00128	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000964	0.00127	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000948	0.00125	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	0.000944	0.00125	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—EGFR—dilated cardiomyopathy	0.000944	0.00125	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	0.000944	0.00125	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000938	0.00124	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000936	0.00124	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—RAF1—dilated cardiomyopathy	0.000936	0.00124	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—EGFR—dilated cardiomyopathy	0.000936	0.00124	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000927	0.00122	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000927	0.00122	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.000923	0.00122	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000905	0.0012	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000901	0.00119	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000891	0.00118	CbGpPWpGaD
Amlexanox—FGF1—Disease—NPPA—dilated cardiomyopathy	0.000891	0.00118	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000888	0.00117	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000888	0.00117	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000877	0.00116	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—EGFR—dilated cardiomyopathy	0.000874	0.00115	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD36—dilated cardiomyopathy	0.000873	0.00115	CbGpPWpGaD
Amlexanox—FGF1—Disease—PSEN2—dilated cardiomyopathy	0.000863	0.00114	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CD36—dilated cardiomyopathy	0.000856	0.00113	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000854	0.00113	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00085	0.00112	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000846	0.00112	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000846	0.00112	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000845	0.00112	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000836	0.0011	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000825	0.00109	CbGpPWpGaD
Amlexanox—S100A12—Immune System—RAC1—dilated cardiomyopathy	0.000822	0.00109	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000822	0.00109	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000809	0.00107	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—RAC1—dilated cardiomyopathy	0.000807	0.00107	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000807	0.00107	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000792	0.00105	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000782	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000775	0.00102	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000768	0.00101	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000757	0.001	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00075	0.000991	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00075	0.000991	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000749	0.000989	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000745	0.000983	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000736	0.000972	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000734	0.00097	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000719	0.00095	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000711	0.000938	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.0007	0.000925	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000698	0.000921	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00069	0.000911	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000687	0.000908	CbGpPWpGaD
Amlexanox—IL3—Immune System—RAF1—dilated cardiomyopathy	0.00068	0.000898	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000676	0.000892	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000663	0.000876	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000659	0.00087	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000656	0.000867	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000653	0.000863	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000653	0.000863	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000648	0.000856	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000643	0.000849	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—EGFR—dilated cardiomyopathy	0.000642	0.000848	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000634	0.000837	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000627	0.000828	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000626	0.000827	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000622	0.000821	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000622	0.000821	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000607	0.000802	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000607	0.000802	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000604	0.000798	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000598	0.00079	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000596	0.000787	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000588	0.000777	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ITGB1—dilated cardiomyopathy	0.000585	0.000772	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00058	0.000766	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000578	0.000763	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000577	0.000762	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000575	0.00076	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000575	0.00076	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00057	0.000752	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00056	0.000739	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000552	0.000728	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000547	0.000723	CbGpPWpGaD
Amlexanox—S100A12—Immune System—RAF1—dilated cardiomyopathy	0.000545	0.00072	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000536	0.000708	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000536	0.000708	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—RAF1—dilated cardiomyopathy	0.000535	0.000707	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000535	0.000706	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000527	0.000696	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000518	0.000684	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000514	0.000678	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000511	0.000674	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000502	0.000663	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000499	0.000659	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD36—dilated cardiomyopathy	0.000499	0.000659	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000483	0.000638	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000478	0.000631	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000477	0.00063	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000477	0.000629	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00047	0.000621	CbGpPWpGaD
Amlexanox—FGF1—Immune System—RAC1—dilated cardiomyopathy	0.00047	0.000621	CbGpPWpGaD
Amlexanox—IL3—Immune System—EGFR—dilated cardiomyopathy	0.000467	0.000616	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000454	0.000599	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000442	0.000584	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00044	0.000581	CbGpPWpGaD
Amlexanox—FGF1—Disease—RAC1—dilated cardiomyopathy	0.000434	0.000573	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000425	0.000561	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00042	0.000554	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000415	0.000548	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000413	0.000545	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00041	0.000541	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000406	0.000536	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000395	0.000522	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000391	0.000517	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00039	0.000515	CbGpPWpGaD
Amlexanox—S100A12—Immune System—EGFR—dilated cardiomyopathy	0.000374	0.000494	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00037	0.000489	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—EGFR—dilated cardiomyopathy	0.000367	0.000484	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000366	0.000483	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000361	0.000476	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AGT—dilated cardiomyopathy	0.000353	0.000467	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000352	0.000465	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000352	0.000465	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000336	0.000444	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000336	0.000444	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000327	0.000432	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000326	0.00043	CbGpPWpGaD
Amlexanox—FGF1—Immune System—RAF1—dilated cardiomyopathy	0.000312	0.000412	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000311	0.000411	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000304	0.000401	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000302	0.000398	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AGT—dilated cardiomyopathy	0.00029	0.000383	CbGpPWpGaD
Amlexanox—FGF1—Disease—RAF1—dilated cardiomyopathy	0.000288	0.00038	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000285	0.000376	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000282	0.000372	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000271	0.000358	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000251	0.000331	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000245	0.000324	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000234	0.000308	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000216	0.000285	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EGFR—dilated cardiomyopathy	0.000214	0.000282	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000201	0.000266	CbGpPWpGaD
Amlexanox—FGF1—Disease—EGFR—dilated cardiomyopathy	0.000197	0.000261	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000193	0.000255	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000168	0.000222	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00016	0.000211	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000148	0.000196	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000138	0.000182	CbGpPWpGaD
